INTERVIEW: Putting a price tag on a company’s social and environmental impact is the only way to demonstrate its true profit and loss, believes Sir Ronald Cohen, who is now focusing on driving forward the next accounting revolution.
INTERVIEW: Founded in 1990s eastern Europe, NESsT is still helping high-impact organisations to grow, and not rely on grants. We hear how it makes extra efforts to track its own impact – and how a new fund is tackling LGBTQIA+ discrimination.
Following record investments in 2021, deals are lower this year, Dealroom’s Impact Database reveals this week. Yet impact startups remain collectively valued at more than US$2tn and “impact unicorns” have reached 200.
INTERVIEW: As B Lab leads a "substantial revisit" of the criteria for companies seeking B Corp status, we ask the man who oversees these standards what will change – and if recent criticism of B Corp certifications is justified.
Company directors’ reliance on international accounting standards means sustainability issues are currently reported separately, if at all. But there are steps they can take to better meet their legal responsibilities, says our columnist.
Sophi Tranchell tells Pioneers Post why she believes equality is the biggest issue facing the modern world, and why it is important to pick perfect partners.
Our WISE100 are never short of wisdom. This time Bonnie Chiu tells us what advice she would give to her 21-year-old self, and why she wants businesses to diversify.
Combining capital with purpose has the “unstoppable” potential to make poverty history – but there's work to do, says Amit Bhatia. Watch him speak as a part of our In the Spotlight series.
Decreasing trust levels, lack of transparency, costly financial models – could blockchain provide the answers to some of the biggest challenges faced in the social impact sector right now? Or are we letting the hype cloud the reality?
Social impact bonds elicit strong opinions – from great enthusiasm about what they could achieve to passionate opposition to their complexity. Mara Airoldi cuts through the noise to take a hard look at the evidence we have about their effectiveness to date.
